JP2023070167A5 - - Google Patents

Download PDF

Info

Publication number
JP2023070167A5
JP2023070167A5 JP2022177048A JP2022177048A JP2023070167A5 JP 2023070167 A5 JP2023070167 A5 JP 2023070167A5 JP 2022177048 A JP2022177048 A JP 2022177048A JP 2022177048 A JP2022177048 A JP 2022177048A JP 2023070167 A5 JP2023070167 A5 JP 2023070167A5
Authority
JP
Japan
Prior art keywords
azabicyclo
alkyl
salt
pharmaceutical composition
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022177048A
Other languages
English (en)
Japanese (ja)
Other versions
JP7743829B2 (ja
JP2023070167A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2023070167A publication Critical patent/JP2023070167A/ja
Publication of JP2023070167A5 publication Critical patent/JP2023070167A5/ja
Application granted granted Critical
Publication of JP7743829B2 publication Critical patent/JP7743829B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022177048A 2021-11-05 2022-11-04 Ｋｄｍ５阻害作用を有する化合物を含有する医薬組成物 Active JP7743829B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021181343 2021-11-05
JP2021181343 2021-11-05

Publications (3)

Publication Number Publication Date
JP2023070167A JP2023070167A (ja) 2023-05-18
JP2023070167A5 true JP2023070167A5 (enExample) 2024-05-02
JP7743829B2 JP7743829B2 (ja) 2025-09-25

Family

ID=86327355

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022177048A Active JP7743829B2 (ja) 2021-11-05 2022-11-04 Ｋｄｍ５阻害作用を有する化合物を含有する医薬組成物

Country Status (1)

Country Link
JP (1) JP7743829B2 (enExample)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0409217A (pt) * 2003-04-09 2006-03-28 Pharmacia & Upjohn Co Llc derivados e análogos antimicrobianos da [3.1.0]bicicloexilfeniloxazolidinona
EP2325180A1 (en) * 2007-10-09 2011-05-25 F. Hoffmann-La Roche AG Chiral CIS-imidazolines
JP6783230B2 (ja) * 2014-10-10 2020-11-11 ジェネンテック， インコーポレイテッド ヒストンデメチラーゼのインヒビターとしてのピロリドンアミド化合物
DK3356345T3 (da) * 2015-09-30 2024-02-12 Max Planck Gesellschaft Heteroaryl-derivater som sepiapterin-reduktase-inhibitorer
WO2021010492A1 (en) * 2019-07-17 2021-01-21 Ono Pharmaceutical Co., Ltd. Compound having kdm5 inhibitory activity and pharmaceutical use thereof
TWI895412B (zh) * 2020-05-07 2025-09-01 日商小野藥品工業股份有限公司 具有kdm5抑制活性之化合物及其醫藥用途
JP2023070165A (ja) * 2021-11-05 2023-05-18 小野薬品工業株式会社 アザビシクロ環化合物の結晶
JP2025029239A (ja) * 2023-08-21 2025-03-06 三菱重工業株式会社 ガスタービン静翼、綴り翼ユニット及びガスタービン静翼の製造方法

Similar Documents

Publication Publication Date Title
US11254658B2 (en) Bisamide sarcomere activating compounds and uses thereof
JP2019077725A5 (enExample)
JP2014521696A5 (enExample)
JP2011500806A5 (enExample)
JP2014511869A5 (enExample)
JP2010533158A5 (enExample)
JP2020506946A5 (enExample)
JP2019537571A5 (enExample)
JP2019518036A5 (enExample)
RU2012116877A (ru) Соединения 2-пиридона, применяемые в качестве ингибиторов нейтрофильной эластазы
JP2013523814A5 (enExample)
JPWO2023064857A5 (enExample)
RU2016112952A (ru) Производные индола и индазола
JP2022017461A5 (enExample)
JP2013525356A5 (enExample)
JPWO2005063737A1 (ja) アミドピラゾール誘導体
JP2009514802A5 (enExample)
JP2015524826A5 (enExample)
JPWO2020216766A5 (enExample)
RU2014123784A (ru) Новые производные пирролидина в качестве ингибиторов катепсина
RU2440349C2 (ru) Производные морфолинопиримидина, полезные для лечения пролиферативных нарушений
RU2019131584A (ru) Комбинация производных изоиндолинона и sgi-110
RU2016146560A (ru) Производные морфолин-пиридина
JP2023070167A5 (enExample)
JP2017516772A5 (enExample)